Updated:
Cura Investment
Cura Investment was established in Shanghai to invest across early-stage and growth equity rounds in Chinese technology companies.
Cura Investment
Cura Investment was established in Shanghai to invest across early-stage and growth equity rounds in Chinese technology companies. The firm's mandate spans seed, start-up, and venture growth stages, with a focus on enterprise-facing sectors including software, artificial intelligence, digital health, and industrial technology. This stage-agnostic approach within a defined set of verticals indicates a strategy built around the firm's ability to identify and scale B2B technology companies serving China's industrial base. The firm's investment strategy targets companies from inception through commercialization, deploying capital at the seed stage and following on through growth rounds. Asset-class exposure is concentrated in direct venture and growth equity, with coverage across enterprise software, AI/ML, digital health, and industrial technology verticals. Cura's geographic footprint is anchored in China, with the Shanghai headquarters placing it within one of China's most active technology investment corridors. Specific portfolio company names and fund sizes have not been disclosed in public records. Cura Investment's operational details — including team size, additional offices, and affiliated vehicles — remain undisclosed in publicly available sources. The firm's prominence in accessible databases is minimal, suggesting it may operate as a closely held vehicle or maintain a deliberately low public profile. No recent operational events, fund closes, or personnel moves have been reported in the past 24 months through English-language financial media or the firm's own public communications channels. Cura's structural differentiator lies in its Shanghai-based, stage-flexible mandate across enterprise technology verticals in China. Unlike firms that rigidly partition seed and growth strategies into separate funds, Cura's single-platform approach to early-stage and growth investing suggests a continuity model in which founding relationships can be maintained as companies mature — a design that rewards origination discipline and long-term engagement with founders navigating China's domestic technology ecosystem.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does Cura Investment target?
Cura Investment deploys across the venture lifecycle, targeting seed, start-up, and growth-stage companies. The firm's mandate enables it to enter at founding and follow capital through later commercialization rounds, primarily within China's enterprise technology sectors.
Which sectors does Cura Investment focus on?
Cura's investment focus includes enterprise software, artificial intelligence and machine learning, digital health, and industrial technology. The firm's sector concentration reflects a thesis built around B2B technology businesses serving China's industrial and corporate economy.
Is Cura Investment structured as a venture capital firm or a private equity firm?
Cura Investment operates as a hybrid venture and growth equity firm, making it both a venture capital manager in its early-stage activities and a private equity manager in its growth-stage deployments. The single-platform structure means seed and growth investments are managed without the fund-line separation typical at larger multi-strategy managers.
Does Cura Investment participate in fund commitments or only direct deals?
Available public records indicate Cura Investment makes direct venture and growth equity investments into Chinese technology companies. The firm's disclosed strategy does not reference fund-of-funds commitments or LP positions in external China-focused venture funds.
Who runs investment decisions at Cura Investment?
Cura Investment has not publicly disclosed its founding team or investment committee members through accessible English-language media, regulatory filings, or its own website. The principals behind the firm remain unknown to public record as of the most recent data available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: